APA

Englisch S., Jung H. S., Lewien A., Becker A., Nowak U., Braun H., Thiem J., Eisenacher S., Meyer-Lindenberg A. & Zink M. (20170412). Agomelatine for the Treatment of Major Depressive Episodes in Schizophrenia-Spectrum Disorders: An Open-Prospective Proof-of-Concept Study. : Journal of clinical psychopharmacology.

Chicago

Englisch Susanne, Jung Hanna Sophie, Lewien Antje, Becker Anna, Nowak Ulrike, Braun Hanna, Thiem Jascha, Eisenacher Sarah, Meyer-Lindenberg Andreas and Zink Mathias. 20170412. Agomelatine for the Treatment of Major Depressive Episodes in Schizophrenia-Spectrum Disorders: An Open-Prospective Proof-of-Concept Study. : Journal of clinical psychopharmacology.

Harvard

Englisch S., Jung H. S., Lewien A., Becker A., Nowak U., Braun H., Thiem J., Eisenacher S., Meyer-Lindenberg A. and Zink M. (20170412). Agomelatine for the Treatment of Major Depressive Episodes in Schizophrenia-Spectrum Disorders: An Open-Prospective Proof-of-Concept Study. : Journal of clinical psychopharmacology.

MLA

Englisch Susanne, Jung Hanna Sophie, Lewien Antje, Becker Anna, Nowak Ulrike, Braun Hanna, Thiem Jascha, Eisenacher Sarah, Meyer-Lindenberg Andreas and Zink Mathias. Agomelatine for the Treatment of Major Depressive Episodes in Schizophrenia-Spectrum Disorders: An Open-Prospective Proof-of-Concept Study. : Journal of clinical psychopharmacology. 20170412.